medison pharma limited
medison pharma limited Company Information
Company Number
08717599
Next Accounts
Jul 2025
Directors
Shareholders
alexey egorov
sunnatkhoja yunuskhodjaev
Group Structure
View All
Industry
Manufacture of basic pharmaceutical products
+1Registered Address
regent house 316a beulah hill, london, SE19 3HF
Website
medison-pharma.commedison pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MEDISON PHARMA LIMITED at £160k based on a Turnover of £237.9k and 0.67x industry multiple (adjusted for size and gross margin).
medison pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MEDISON PHARMA LIMITED at £0 based on an EBITDA of £-3.6k and a 3.77x industry multiple (adjusted for size and gross margin).
medison pharma limited Estimated Valuation
Pomanda estimates the enterprise value of MEDISON PHARMA LIMITED at £5.3k based on Net Assets of £2.9k and 1.85x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medison Pharma Limited Overview
Medison Pharma Limited is a live company located in london, SE19 3HF with a Companies House number of 08717599. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in October 2013, it's largest shareholder is alexey egorov with a 76% stake. Medison Pharma Limited is a established, micro sized company, Pomanda has estimated its turnover at £237.9k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medison Pharma Limited Health Check
Pomanda's financial health check has awarded Medison Pharma Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
7 Weak
Size
annual sales of £237.9k, make it smaller than the average company (£28.6m)
- Medison Pharma Limited
£28.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a similar rate (5.1%)
- Medison Pharma Limited
5.1% - Industry AVG
Production
with a gross margin of 17.6%, this company has a higher cost of product (33%)
- Medison Pharma Limited
33% - Industry AVG
Profitability
an operating margin of -1.5% make it less profitable than the average company (5.2%)
- Medison Pharma Limited
5.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (73)
1 - Medison Pharma Limited
73 - Industry AVG
Pay Structure
on an average salary of £69.1k, the company has an equivalent pay structure (£69.1k)
- Medison Pharma Limited
£69.1k - Industry AVG
Efficiency
resulting in sales per employee of £237.9k, this is less efficient (£526.6k)
- Medison Pharma Limited
£526.6k - Industry AVG
Debtor Days
it gets paid by customers after 83 days, this is later than average (57 days)
- Medison Pharma Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 96 days, this is slower than average (35 days)
- Medison Pharma Limited
35 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medison Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Medison Pharma Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.8%, this is a higher level of debt than the average (52.6%)
94.8% - Medison Pharma Limited
52.6% - Industry AVG
MEDISON PHARMA LIMITED financials
Medison Pharma Limited's latest turnover from October 2023 is estimated at £237.9 thousand and the company has net assets of £2.9 thousand. According to their latest financial statements, Medison Pharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 71,951 | |||||||||
| Intangible Assets | ||||||||||
| Investments & Other | ||||||||||
| Debtors (Due After 1 year) | ||||||||||
| Total Fixed Assets | 71,951 | |||||||||
| Stock & work in progress | ||||||||||
| Trade Debtors | 54,431 | 59,488 | 49,646 | 53,179 | 53,387 | 23,045 | 6,106 | 6,888 | ||
| Group Debtors | ||||||||||
| Misc Debtors | ||||||||||
| Cash | 196 | |||||||||
| misc current assets | ||||||||||
| total current assets | 54,431 | 59,488 | 49,646 | 53,179 | 53,387 | 23,045 | 6,302 | 6,888 | ||
| total assets | 54,431 | 59,488 | 49,646 | 53,179 | 53,387 | 71,951 | 23,045 | 6,302 | 6,888 | |
| Bank overdraft | ||||||||||
| Bank loan | ||||||||||
| Trade Creditors | 51,578 | 53,008 | 45,597 | 30,158 | 29,430 | 36,932 | 4,822 | 3,957 | 2,418 | 5,496 |
| Group/Directors Accounts | ||||||||||
| other short term finances | ||||||||||
| hp & lease commitments | ||||||||||
| other current liabilities | ||||||||||
| total current liabilities | 51,578 | 53,008 | 45,597 | 30,158 | 29,430 | 36,932 | 4,822 | 3,957 | 2,418 | 5,496 |
| loans | ||||||||||
| hp & lease commitments | ||||||||||
| Accruals and Deferred Income | ||||||||||
| other liabilities | 17,265 | 17,257 | 28,540 | 12,801 | ||||||
| provisions | ||||||||||
| total long term liabilities | 17,265 | 17,257 | 28,540 | 12,801 | ||||||
| total liabilities | 51,578 | 53,008 | 45,597 | 47,423 | 46,687 | 65,472 | 17,623 | 3,957 | 2,418 | 5,496 |
| net assets | 2,853 | 6,480 | 4,049 | 5,756 | 6,700 | 6,479 | 5,422 | -3,957 | 3,884 | 1,392 |
| total shareholders funds | 2,853 | 6,480 | 4,049 | 5,756 | 6,700 | 6,479 | 5,422 | -3,957 | 3,884 | 1,392 |
| Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | ||||||||||
| Amortisation | ||||||||||
| Tax | ||||||||||
| Stock | ||||||||||
| Debtors | -5,057 | 9,842 | -3,533 | -208 | 53,387 | -23,045 | 23,045 | -6,106 | -782 | 6,888 |
| Creditors | -1,430 | 7,411 | 15,439 | 728 | -7,502 | 32,110 | 865 | 1,539 | -3,078 | 5,496 |
| Accruals and Deferred Income | ||||||||||
| Deferred Taxes & Provisions | ||||||||||
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | ||||||||||
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | ||||||||||
| Other Short Term Loans | ||||||||||
| Long term loans | ||||||||||
| Hire Purchase and Lease Commitments | ||||||||||
| other long term liabilities | -17,265 | 8 | -11,283 | 15,739 | 12,801 | |||||
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | -196 | 196 | ||||||||
| overdraft | ||||||||||
| change in cash | -196 | 196 |
medison pharma limited Credit Report and Business Information
Medison Pharma Limited Competitor Analysis
Perform a competitor analysis for medison pharma limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in SE19 area or any other competitors across 12 key performance metrics.
medison pharma limited Ownership
MEDISON PHARMA LIMITED group structure
Medison Pharma Limited has no subsidiary companies.
medison pharma limited directors
Medison Pharma Limited currently has 1 director, Mr Alexey Egorov serving since Oct 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alexey Egorov | United Kingdom | 64 years | Oct 2013 | - | Director |
P&L
October 2023turnover
237.9k
-2%
operating profit
-3.6k
0%
gross margin
17.6%
+3.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
October 2023net assets
2.9k
-0.56%
total assets
54.4k
-0.09%
cash
0
0%
net assets
Total assets minus all liabilities
medison pharma limited company details
company number
08717599
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
46460 - Wholesale of pharmaceutical goods
incorporation date
October 2013
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
October 2023
previous names
N/A
accountant
-
auditor
-
address
regent house 316a beulah hill, london, SE19 3HF
Bank
-
Legal Advisor
-
medison pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medison pharma limited.
medison pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDISON PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
medison pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
